default author photo

Paolo Corradini

University of Milan

Via Festa del Perdono, 7

Milan, 20122

Italy

SCHOLARLY PAPERS

3

DOWNLOADS

264

TOTAL CITATIONS

2

Scholarly Papers (3)

Actions:
Email selected abstracts
1.

Updated 13 Yr Follow-Up of the GITMO-IIL Trial Comparing Upfront R-HDS with Autograft vs. CHOP-R in High-Risk Follicular Lymphoma: Prolonged Survival in Both Arms and a High Rate of Long-Term Disease Free Survivors

Number of pages: 84 Posted: 20 Sep 2018
Riccardo Bruna, Fabio Benedetti, Carola Boccomini, Caterina Patti, Anna Maria Barbui, Alessandro Pulsoni, Maurizio Musso, Anna Marina Liberati, Guido Gini, Claudia Castellino, Fausto Rossini, Fabio Ciceri, Delia Rota-Scalabrini, Caterina Stelitano, Francesco Di Raimondo, Alessandra Tucci, Liliana Devizzi, Valerio Zoli, Francesco Zallio, Franco Narni, Alessandra Dondi, Guido Parvis, Gianpietro Semenzato, Francesco Lanza, Tommasina Perrone, Francesco Angrilli, Atto Billio, Angela Gueli, Barbara Mantoan, Alessandro Rambaldi, Alessandro Massimo Gianni, Paolo Corradini, Roberto Passera, Marco Ladetto and Corrado Tarella
IEO Istituto Europeo di Oncologia IRCCS, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Città Della Salute e della Scienza, Azienda Villa Sofia-Cervello, Papa Giovanni XXIII Hospital, Sapienza University of Rome, La Maddalena Hospital, Università degli Studi di Perugia, Hematology Univ. Div., Ospedale Santa Croce E Carle, Ospedale San Gerardo, 12hematology Unit HSR, Oncologia Medica, Cancer Inst. FPO, IRCCS, Hematology Div, Hematology Univ, Hematology Div, Oncology univ. Div., 18Hematology Div., Hematology Div., Azienda Ospedaliero Universitaria di Modena, Azienda Ospedaliero Universitaria di Modena, San Luigi Hospital, Hematology Univ. Div., Hematology Unit, Hematology Univ. Div., Hematology Div., Independent, IEO Istituto Europeo di Oncologia IRCCS, Città Della Salute e della Scienza, Papa Giovanni XXIII Hospital, IEO Istituto Europeo di Oncologia IRCCS, University of Milan, Città Della Salute e della Scienza, Independent and IEO Istituto Europeo di Oncologia IRCCS - Divisione Universitaria di Ematologia
Downloads 121 (592,433)

Abstract:

Loading...

Follicular Lymphoma, Chemo-immunotherapy, Survival, Complete Remission, Molecular Remission

2.

Timing the Initiation of Multiple Myeloma

Number of pages: 122 Posted: 25 Jun 2019
Even H. Rustad, Venkata Yellapantula, Niccolo Bolli, Daniel Leongamornlert, Ferran Nadeu, Nicos Angelopoulos, Kevin J. Dawson, Thomas J. Mitchell, Rob Osborne, Bachisio Ziccheddu, Cristiana Cariniti, Vittorio Montefusco, Paolo Corradini, Kenneth C. Anderson, Philippe Moreau, Elli Papaemmanuil, Ludmil Alexandrov, Xose S. Puente, Elias Campo, Reiner Siebert, Herve Avet-Loiseau, Ola Landgren, Nikhil Munshi, Peter J. Campbell and Francesco Maura
Memorial Sloan Kettering Cancer Center - Myeloma Service, Memorial Sloan Kettering Cancer Center - Myeloma Service, University of Milan, Faculty of Medicine, Oncology and Hemato-Oncology Department, Wellcome Sanger Institute, University of Barcelona - Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Essex, Wellcome Sanger Institute, Wellcome Sanger Institute, Wellcome Sanger Institute, University of Milan, Faculty of Medicine, Oncology and Hemato-Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Fondazione IRCCS Istituto Nazionale dei Tumori - Division of Hematology and Bone Marrow Transplantation, University of Milan, Harvard University - Dana-Farber Cancer Institute, University of Nantes, Memorial Sloan Kettering Cancer Center - Myeloma Service, University of California, San Diego (UCSD) - Moores Cancer Center, University of Barcelona, Patologia Molecular de Neoplàsies Limfoides, Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Ulm University, IUC-Oncopole, Memorial Sloan Kettering Cancer Center - Myeloma Service, Harvard University - Dana-Farber Cancer Institute, Wellcome Genome Campus - Cancer Genome Project and Memorial Sloan Kettering Cancer Center - Myeloma Service
Downloads 84 (777,583)
Citation 2

Abstract:

Loading...

Multiple Myeloma, Mutational Signatures, Molecular Time, Cancer Initiation, Germinal Center

3.

Bortezomib, Cyclophosphamide, Dexamethasone Versus Lenalidomide, Cyclophosphamide, Dexamethasone in Multiple Myeloma Patients at First Relapse

Number of pages: 100 Posted: 10 Nov 2018
Vittorio Montefusco, Alessandro Corso, Monica Galli, Ilaria Ardoino, Sara Pezzatti, Cristina Carniti, Francesca Patriarca, Filippo Gherlinzoni, Renato Zambello, Simona Sammassimo, Magda Marcatti, Andrea Nozza, Claudia Crippa, Anna Maria Cafro, Luca Baldini and Paolo Corradini
Fondazione IRCCS Istituto Nazionale dei Tumori - Division of Hematology and Bone Marrow Transplantation, Fondazione IRCCS Policlinico San Matteo, Papa Giovanni XXIII Hospital, Istituto di Ricerche Farmacologiche, Università degli Studi di Milano-Bicocca - Fondazione MBBM/San Gerardo Hospital, Fondazione IRCCS Istituto Nazionale dei Tumori, Università degli Studi di Udine, Hematology, Ca’ Foncello Hospital, University of Padua, European Institute of Oncology (IEO) IRCCS, Università Vita-Salute San Raffaele - IRCCS San Raffaele Scientific Institute, Istituto Clinico Humanitas, ASST-Spedali Civili of Brescia, Niguarda Ca' Granda Hospital, University of Milan and University of Milan
Downloads 59 (970,490)

Abstract:

Loading...

Multiple myeloma,lenalidomide, bortezomib